ADUS — Addus HomeCare Corporation stock price, charts and financials

NASDAQ·Healthcare·Medical - Care Facilities·USA

Latest market price

113.66

-3.13-2.68%

Overview Short InterestFilings

ADUSQT54Addus HomeCare Corporation·NASDAQ

Overview Short InterestFilings

113.66-2.68%

Filing

Down 2.7% — Filed an 8-K material-event report (2026-08-03) — details in the filing.

Medium confidence

Loading chart...

Signal & projected range

Gap down — mean-reversionHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

SGRY-2.55%$15.65 SEM-0.12%$16.51 AVAH-2.60%$9.36 MD-5.87%$24.71 ASTH-0.67%$35.67 GRDN-0.69%$40.53 HCSG-1.11%$23.15 AGL+0.71%$94.78

Snapshot

Index	-	P/E	21.01	EPS (ttm)	5.41	Insider Own	6.67%	Shs Outstand	18.66M	Perf Week	-4.66%

Market Cap	2.12B	Forward P/E	15.16	EPS next Y	7.50	Insider Trans	-2.27%	Shs Float	18.13M	Perf Month	7.50%

Enterprise Value	2.14B	PEG	3.19	EPS next Q	-	Inst Own	-	Short Float	6.91%	Perf Quarter	13.52%

Income	100.00M	P/S	1.47	EPS this Y	29.63%	Inst Trans	-	Short Ratio	4.90	Perf Half Y	7.92%

Sales	1.45B	P/B	1.90	EPS next Y	6.92%	ROA	6.95%	Short Interest	1.25M	Perf YTD	5.84%

Book/sh	59.79	P/C	20.60	EPS next 5Y	6.58%	ROE	9.34%	52W High	124.44 -8.66%	Perf Year	8.29%

Cash/sh	5.52	P/FCF	15.69	EPS past 3/5Y	22.42% 20.16%	ROIC	8.21%	52W Low	87.95 29.23%	Perf 3Y	25.47%

Dividend Est.	-	EV/EBITDA	13.31	Sales past 3/5Y	14.38% 13.22%	Gross Margin	32.45%	Volatility	3.44% 3.12%	Perf 5Y	36.94%

Dividend TTM	-	EV/Sales	1.48	EPS Y/Y TTM	27.90%	Oper. Margin	9.82%	ATR (14)	3.68	Perf 10Y	483.77%

Dividend Ex-Date	-	Quick Ratio	1.83	Sales Y/Y TTM	25.37%	Profit Margin	6.89%	RSI (14)	57.66	Recom	2.19

Dividend Gr. 3/5Y	-	Current Ratio	1.83	EPS Q/Q	14.08%	SMA20	0.61%	Beta	0.84	Target Price	117.50

Payout	0.00%	Debt/Eq	0.19	Sales Q/Q	7.69%	SMA50	11.11%	Rel Volume	1.51	Prev Close	116.79

Employees	50,659	LT Debt/Eq	0.18	Earnings	Nov 02	SMA200	7.77%	Avg Volume	257.48K	Price	113.66

IPO Date	Oct 28, 2009	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.86% -0.79%	Net Debt/EBITDA	0.22	Volume	388,947	Change	-2.68%

Analyst Ratings

Date	Action	Analyst	Rating	Target
May-15-26	Reiterated	Barclays	Underweight	$112 → $92
Feb-25-26	Reiterated	RBC Capital	Outperform	$141 → $139
Feb-24-26	Reiterated	Barclays	Underweight	$117 → $112
Jan-07-26	Initiated	Truist	Buy	$135
Nov-04-25	Reiterated	Barclays	Underweight	$83 → $117
Sep-02-25	Initiated	UBS	Buy	$145
Dec-16-24	Initiated	JMP Securities	Outperform	$150
Nov-06-24	Reiterated	Stephens & Co.	Overweight	$128 → $145
Oct-10-24	Initiated	KeyBanc	Overweight	$150
Sep-23-24	Reiterated	Oppenheimer	Outperform	$140 → $145

Latest News

Aug-04-26

Aug-04-2605:30PM

Addus HomeCare Corporation (ADUS) Q2 2026 Earnings Call Transcriptseekingalpha.com

11:06AM

Addus HomeCare Q2 Earnings Call Highlightsmarketbeat.com

Aug-03-26

Aug-03-2607:31PM

Addus HomeCare (ADUS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimateszacks.com

06:46PM

Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimateszacks.com

04:05PM

Addus HomeCare Announces Second Quarter 2026 Financial Resultsbusinesswire.com

Jul-20-26

Jul-20-2611:00AM

Addus HomeCare Announces Second Quarter 2026 Earnings Release and Conference Callbusinesswire.com

Jul-09-26

Jul-09-2609:13AM

Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $96Benzinga

Jun-17-26

Jun-17-2610:10AM

Addus HomeCare Corp. (NASDAQ:ADUS) Quality Investing Analysis Using the Caviar Cruise ScreenChartMill

Company

Addus HomeCare Corporation, through its various subsidiaries, offers essential personal support services across the United States. The company primarily assists seniors, individuals with chronic illnesses or disabilities, and those at risk of hospitalization or institutionalization. Its operations are structured into three primary segments: Personal Care, Hospice, and Home Health. The Personal Care division delivers non-medical assistance with daily living activities, including help with personal hygiene (bathing, grooming, oral care), eating, dressing, medication reminders, meal preparation, household chores, and transportation. Through its Hospice segment, Addus provides compassionate palliative nursing care, social work, spiritual guidance, homemaker services, and bereavement support to terminally ill individuals and their families. The Home Health segment delivers professional skilled nursing care alongside physical, occupational, and speech therapy for patients recovering from illness or following a hospital discharge. Addus HomeCare's diverse client base includes federal, state, and local government entities, managed care organizations, commercial insurance providers, and private-paying individuals. As of December 31, 2021, the company served consumers through a network of 206 offices located across 22 states. Established in 1979, Addus HomeCare Corporation is headquartered in Frisco, Texas.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	1,448	1,423	1,155	1,059	951	864	765	649	518
Cost of Goods Sold Incl. D&A	979	961	780	719	651	595	539	470	380
Gross Profit	471	462	375	340	300	270	226	179	138
Selling, General and Administrative Excl. Other	311	307	259	232	217	189	170	134	105
Research and Development	0	0	0	0	0	0	0	0	0
Other Operating Expense	17	16	13	17	14	14	12	10	9
Operating Income	142	139	103	91	69	66	45	35	23
Interest Expense	12	10	8	11	9	6	3	3	5
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	4	-2	4	1	0	0	1	2	3
Net Income Before Taxes	132	127	99	81	60	60	42	33	20
Income Taxes	33	32	26	19	14	15	9	7	4
Consolidated Net Income	100	96	74	63	46	45	33	25	18
Net Income From Continuing Operations	100	96	74	63	46	45	33	26	16
Net Income	100	96	74	63	46	45	33	25	18
EPS (Recurring)	5.41	5.19	4.33	3.91	2.90	2.87	2.12	1.83	1.33
EPS (Basic, Before Extraordinaries)	5.41	5.19	4.33	3.91	2.90	2.87	2.12	1.83	1.33
EPS (Diluted)	5.41	5.21	4.23	3.83	2.84	2.81	2.08	1.77	1.33
EBITDA	161	153	121	107	83	81	57	47	34
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	21.01	20.61	29.63	24.24	35.03	33.28	56.29	54.93	51.04
Price To Sales Ratio	1.41	1.36	1.84	1.40	1.67	1.73	2.45	2.10	1.70
Gross Margin	32.53	32.47	32.47	32.11	31.55	31.25	29.54	27.58	26.64
Operating Margin	9.81	9.77	8.92	8.59	7.26	7.64	5.88	5.39	4.44
Net Margin	6.91	6.75	6.41	5.95	4.84	5.21	4.31	3.85	3.47
Shares Outstanding	18	18	17	16	16	16	16	14	13
Market Capitalization	2,046	1,933	2,131	1,486	1,592	1,496	1,873	1,361	882
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dixon Heather Brianne	President and Chief Operating	Jun 22 '26	Sale	93.77	288	27,006	44,371	Jun 23
Lopez Esteban	Director	May 21 '26	Sale	93.00	250	23,250	3,200	May 22
Lopez Esteban	Director	May 19 '26	Sale	93.00	250	23,250	3,450	May 21
BLESSING CLIFF DONALD	EVP, Chief Development Officer	Apr 21 '26	Sale	93.61	178	16,663	12,183	Apr 22
RAINES MONICA	EVP, CCO and Quality Officer	Mar 02 '26	Sale	102.15	224	22,882	13,577	Mar 03
WATTENBARGER MICHAEL D.	EVP, Chief Information Officer	Feb 25 '26	Sale	105.36	300	31,608	9,444	Feb 26
RAINES MONICA	EVP, CCO and Quality Officer	Feb 25 '26	Sale	105.36	219	23,074	13,801	Feb 26
Stevenson Roberton James	EVP, Chief HR Officer	Feb 25 '26	Sale	105.36	284	29,922	14,030	Feb 26
BLESSING CLIFF DONALD	EVP, Chief Development Officer	Feb 25 '26	Sale	105.36	177	18,649	12,361	Feb 26
TUCKER DAVID W.	EVP, Chief Strategy Officer	Feb 25 '26	Sale	105.36	379	39,931	10,423	Feb 26
Anderson Darby	EVP, Chief Govt Rel Officer	Feb 25 '26	Sale	105.36	396	41,723	46,246	Feb 26
GAFFNEY SEAN	EVP, Chief Legal Officer	Feb 25 '26	Sale	105.36	442	46,569	20,080	Feb 26
POFF BRIAN	EVP, Chief Financial Officer	Feb 25 '26	Sale	105.36	820	86,395	63,692	Feb 26
ALLISON R DIRK	Chairman and CEO	Feb 25 '26	Sale	105.36	2,364	249,071	183,150	Feb 26
TUCKER DAVID W.	EVP, Chief Strategy Officer	Feb 24 '26	Sale	107.35	704	75,574	10,802	Feb 26

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.